Is it time to shift to better characterization of patients in trials assessing novel antidepressants? An example of two relapse prevention studies with agomelatine - Goodwin, G; Boyer, P; Emsley, R; Rouillon, F; De Bodinat, C (International Clinical Psychopharmacology, 2013)